Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian, F., Engst, S., Yamaguchi, K., Yu, P., Won, K.A., Mock, L., Lou, T., Tan, J., Li, C., Tam, D., Lougheed, J., Yakes, F.M., Bentzien, F., Xu, W., Zaks, T., Wooster, R., Greshock, J., Joly, A.H.(2009) Cancer Res 69: 8009-8016
- PubMed: 19808973 
- DOI: 10.1158/0008-5472.CAN-08-4889
- Primary Citation of Related Structures:  
3LQ8 - PubMed Abstract: 
The Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), are overexpressed and/or activated in a wide variety of human malignancies. Vascular endothelial growth factor (VEGF) receptors are expressed on the surface of vascular endothelial cells and cooperate with Met to induce tumor invasion and vascularization ...